Navigation Links
Patient Safety Technologies Announces Expansion of Senior Management Team
Date:1/8/2009

Medical Device Veteran David Bruce Joins as President and Chief Executive Officer

TEMECULA, Calif., Jan. 8 /PRNewswire-FirstCall/ -- Patient Safety Technologies (OTC Bulletin Board: PSTX) today announced that David Bruce has joined the company as its President and Chief Executive Officer and will also join its Board of Directors. Bill Adams, the company's former Chief Executive Officer will remain involved with the company as a consultant.

David brings a breadth of experience successfully managing the growth of medical device businesses. Most recently, David was the Chief Executive Officer of EP MedSystems, Inc., a developer of electrophysiology devices, which was recently acquired by St. Jude Medical. Prior to EP MedSystems, he was the General Manager of the intracardiac echo group of Siemens Medical.

Regarding joining the company, Mr. Bruce stated, "The Safety-Sponge(TM) System addresses a persistent problem that costs U.S. hospitals a conservatively estimated $700 million annually - retained surgical sponges. With key adopters continuing to show outstanding results, this proven system is well positioned to achieve widespread adoption and allow our customers to not only offer a higher standard of patient care but enable them to save money in the process."

About Patient Safety Technologies

Patient Safety Technologies, Inc. (OTC Bulletin Board: PSTX), through its wholly owned subsidiary SurgiCount Medical, Inc., provides the Safety-Sponge(TM) System, a patented FDA 510k approved turn key solution to prevent retained surgical sponges. The system is comprised of surgical sponges and towels affixed with an inseparable two-dimensional data matrix bar code and a SurgiCounter scanner to record each sponge before and after an operation. The SurgiCount Safety-Sponge(TM) System is also the only retained sponge prevention system to offer complete sponge inventory tracki
'/>"/>

SOURCE Patient Safety Technologies
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...cialist manufacturers who use medical load cells a...of dollars by bringing in technology partner Flint... of pro-active medical manufacturers are calling i...f their projects, ensuring that progress will not ...entially outdated technology. , ...
(Date:11/26/2009)...g tetrathiomolybdate (TM) has been shown in studie...se, a disease caused by an overload of copper, and...ery little, however, is known about how the drug w...y Northwestern University researchers now has prov...ucture of TM bound to copper-loaded metallochapero...
(Date:11/26/2009)...earch Triangle Dental (RTDental), a leading dental...nnounced the expansion of its services to include ...g Macmillan. , Durham,... to announce that Dr. Doug Macmillan, an experienc...tional advanced training seminar. RTDental’...
(Date:11/25/2009)....25/PRNewswire-FirstCall/-- OnyxPharmaceuticals,I...hosttwoinvestoreventsinDecember: ,, ASHBriefi... ,, Principalinvestigatorswilldiscussdatapres...ractorymultiplemyeloma,asfeaturedatthe51stAmerican...inNewOrleans,LA.Theteleconferencewillbeginat9:00a....
(Date:11/25/2009)...ewswire-USNewswire/--TheBlackAIDSInstituterecently...adershipfor2010. ,, ThenewBoardMembersareahighl...y,law,finance,governmenthealthprograms,editorial,a...iderangeofpersonalbackgroundsincludingbothheterose...lves,andrepresentingmultipleagegroups. ,, (Phot...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2
... of Switzerland finds children who are exposed to ... also have asthma or allergies. Researchers had pa...ires// regarding asthma and hay fever. They also t...r levels of endotoxin, a component of the cell wal...
...hen it comes to health issues. In California, trav...o smoke for residents. Environmental tobacco smoke...nge of adverse health effects - from exacerbation ...sity of California have studied a group of 200 peo...
... with mood disorders who have attempted suicide ar...ll. The link is especially strong among those who ...suffer from mood disorders themselves. Resear...people at especially high risk. Researchers from t...
...tion may unclog a mechanical heart pump, reconditi...researcher from University Hospital in Germany,// ...ous problem for heart failure patients who receive...pumping ability of a heart that can't dynamically ...
...preventable cause of death. Turning off the televi...w study finds the more an adolescent watches telev...//The risk of disease increases the earlier in lif...ising on television, smoking is still widespread o...
...th a higher dose of radiotherapy, with weekends o...involves a daily dose of radiotherapy five days a ...n found from a more intensive programme known as C... computer models, they suggested that a higher dos...
Other Medicine News:
(Date:11/27/2009)...PRNewswire/--ACUOTECHNOLOGIES,developersofhigh-per...ontoolsandservices,ispleasedtoannouncethattheUnite...pplicationforan"AssetCommunicationFormatwithinaCom....patenttoitsportfolioofintellectualproperty.Ingene...,stechnologyanduseofassetmetainformationtocontrolr...
(Date:11/25/2009)...Newswire-FirstCall/--HeskaCorporation(HSKA);("Hesk...altyproductstotheveterinaryindustry,announcedtoday...plyofbloodgasproductsandaffiliatedconsumablesforth....com/cgi-bin/prnh/20000622/HESKALOGO ) ,, "Hesk...dofadvancedpoint-of-carediagnostics,"commentedMich...
(Date:11/25/2009)...ire/--BioTrendsResearchGroup,Inc.releasedWave1ofit...amulti-phasesyndicatedmarketresearchprojecttrackin...ductlaunchthroughthefirstsixmonthsofavailability.E...rom75uniqueDermatologistsandqualitativeinformation...ra,obstaclestouse,typicalpatienttypes,productperce...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v Levine and Pandemic Influenza 48072 1DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v Levine and Pandemic Influenza 48072 2DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v Levine and Pandemic Influenza 48072 3Government of Canada announces funding for research on the H1N1 flu virus 8732 1Government of Canada announces funding for research on the H1N1 flu virus 8732 2Ludwig Institute of Cancer Research Ltd Brussels Branch Issues Statement Concerning Prospect Therapeutics Incs GCS 100 Molecule 48071 1Ludwig Institute of Cancer Research Ltd Brussels Branch Issues Statement Concerning Prospect Therapeutics Incs GCS 100 Molecule 48071 2
...x S.A.,(Eurolist: COX) today announced that Merck ... planned clinical studies, in mild to moderate,hyp...tive agreement to,develop new nitric oxide-donatin...technology. Three drug candidates have now been se... of which two have completed initial,dose ranging ...
...n Prevention Business, DUBLIN, Ohio, May 12 Card...vices that improve the safety and,productivity of ...acquisition of assets of privately held Enturia, I...ucts sold under the ChloraPrep(R) brand name., Ch... hospitals and,surgery centers as a patient preope...
Other Medicine Technology:NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 2NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 3Cardinal Health Completes Enturia Acquisition 2
Gamma GT (GLUPA)
Creatine Kinase (CK-NAC) SZASZ
Cholesterol (CHOD-PAP) (DIMENSION)
Cholesterol (Liquid)
Medicine Products: